Convert Pharmaceuticals
Pre-clinicalDevelops novel cancer therapies using hypoxia-activated prodrugs.
Founded
2015
Focus
Small Molecules
About
Develops novel cancer therapies using hypoxia-activated prodrugs.
Company Info
TypePrivate
Founded2015
LocationLeuven, Belgium
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
Miracor Medical
Pre-clinical · Zaventem
AML Clinical Services
Pre-clinical · Leuven
Anacura
Pre-clinical · Ghent
Aseptic Technologies
Pre-clinical · Gembloux
Aspect Analytics
Pre-clinical · Leuven
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile